Physician profile
Diane Hughes
NPI 1649273806
$912.20
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $16.02 · 2021: $101 · 2022: $538 · 2023: $63.68 · 2024: $74.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $356.88 | 2022 | |
| Astellas Pharma US INC | $116.87 | 2022-2024 | Veozah |
| Hologic Sales and Service, LLC | $55.14 | 2019-2021 | |
| Gilead Sciences, INC. | $44.96 | 2021 | |
| Medtronic, INC. | $42.93 | 2023-2024 | Truclear |
| Abbvie INC. | $34.97 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $33.66 | 2022-2023 | |
| Caldera Medical, INC | $29.22 | 2023 | Desara |
| Myovant Sciences INC. | $28.66 | 2022 | |
| Gynesonics, INC. | $28.25 | 2021 | |
| Vertical Pharmaceuticals, LLC | $22.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.24 | 2019 | |
| Shield Therapeutics INC | $20.00 | 2022 | |
| Merck Sharp & Dohme LLC | $18.51 | 2022 | |
| Avanos Medical | $18.34 | 2024 | On-Q* Pump and Accessories |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $16.78 | 2019 | |
| Medtronic Vascular, INC. | $11.63 | 2019 | |
| Aspira Women'S Health INC | $11.40 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.